KRONOX — Kronox Lab Sciences Income Statement
0.000.00%
- IN₹5.81bn
- IN₹5.67bn
- IN₹955.78m
- 75
- 16
- 69
- 55
Annual income statement for Kronox Lab Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 505 | 625 | 822 | 956 |
Cost of Revenue | ||||
Gross Profit | 241 | 276 | 344 | 402 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 398 | 496 | 646 | 751 |
Operating Profit | 107 | 128 | 177 | 205 |
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 117 | 132 | 184 | 223 |
Provision for Income Taxes | ||||
Net Income After Taxes | 85.9 | 97.3 | 136 | 166 |
Net Income Before Extraordinary Items | ||||
Net Income | 85.9 | 97.3 | 136 | 166 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 85.9 | 97.3 | 136 | 166 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 2.32 | 2.62 | 3.67 | 4.42 |
Dividends per Share |